Sign In
Buy ESLOY
$98.17
-0.98 (-0.99%)
At Close: Jun 03, 2026
EssilorLuxottica completes acquisition of Optegra
02:00pm, Wednesday, 01'st Oct 2025
EssilorLuxottica completes acquisition of Optegra Paris, France (1 October 2025) – EssilorLuxottica announces that it has successfully completed the acquisition of Optegra from MidEuropa. Under the
ZBH vs. ESLOY: Which Stock Is the Better Value Option?
12:40pm, Monday, 29'th Sep 2025
Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet (ZBH) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two companies is the best opti
EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
05:30pm, Thursday, 25'th Sep 2025
Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
EssilorLuxottica: EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future
09:30pm, Wednesday, 17'th Sep 2025
EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future
Ted Weisberg's Picks: META, ESLOY, Dividend Stocks
06:00pm, Monday, 15'th Sep 2025
Ted Weisberg discusses why a 25 basis point cut is the right move this week and names some stock picks. He's a long time Meta (META) bull and thinks it can continue to climb, calling it “reasonably
ZBH or ESLOY: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 12'th Sep 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Zimmer Biomet (ZBH) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks present
ZBH vs. ESLOY: Which Stock Is the Better Value Option?
12:41pm, Wednesday, 27'th Aug 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Zimmer Biomet (ZBH) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks offers
EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing
EssilorLuxottica: Publication of the 2025 Interim Financial Report
12:30pm, Tuesday, 29'th Jul 2025
Publication of the 2025 Interim Financial Report Paris, France (29 July 2025 – 6:30 pm) – The Board of Directors of EssilorLuxottica met on July 28, 2025 to approve the condensed consolidated inte
EssilorLuxottica earnings boost illustrates growth potential for Meta's smartglasses
07:49am, Tuesday, 29'th Jul 2025
Sales of EssilorLuxottica's Ray-Ban Meta smartglasses tripled in the first half of 2025
Ray-Ban Meta smart glasses revenue tripled over the year, EssilorLuxottica says
05:51pm, Monday, 28'th Jul 2025
Revenue from sales of Ray-Ban Meta smart glasses more than tripled year over year, EssilorLuxottica revealed Monday as part of the company's most recent earnings report. EssilorLuxottica said the succ
EssilorLuxottica (ESLOF) Q2 2025 Earnings Call Transcript
05:22pm, Monday, 28'th Jul 2025
EssilorLuxottica (OTCPK:ESLOF) Q2 2025 Earnings Conference Call July 28, 2025 12:30 PM ET Company Participants Francesco Milleri - Non-Independent Chairman & CEO Giorgio Iannella - Head of Investor Re
Ray-Ban Meta Sales Triple as Glasses Become ‘Next Computing Platform'
04:31pm, Monday, 28'th Jul 2025
EssilorLuxottica, which partners with Meta on artificial intelligence (AI) glasses, reported Monday (July 28) that the sales of those Ray-Ban Meta glasses were up more than 200% in the first half of t
EssilorLuxottica: Q2/H1 2025 Results - Sound revenue growth at 7.3% in Q2 and H1, AI glasses speeding up further
12:00pm, Monday, 28'th Jul 2025
Sound revenue growth at 7.3% in Q2 and H1 AI glasses speeding up further Group's revenue growing 7.3% in both Q2 and H1 (constant exchange rates 1 ) North America accelerating in PS, DTC keeping a sol
EssilorLuxottica to acquire PUcore's division dedicated to the development, manufacturing and sale of ophthalmic lens materials
02:00am, Monday, 21'st Jul 2025
EssilorLuxottica to acquire PUcore's division dedicated to the development, manufacturing and sale of ophthalmic lens materials
